お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
967669

再生医療市場:世界の業界動向・シェア・市場規模・成長・機会・予測 (2020-2025年)

Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 141 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
再生医療市場:世界の業界動向・シェア・市場規模・成長・機会・予測 (2020-2025年)
出版日: 2020年10月16日
発行: IMARC Services Private Limited
ページ情報: 英文 141 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における再生医療の市場規模は、2014年から2019年間に約16%のCAGRで成長しました。

世界的な慢性疾患や遺伝性疾患の有病率の上昇は、市場の成長を推進する重要な要因の1つです。さらに、さまざまな筋骨格系、腫瘍学的、皮膚科、および心臓病の障害を起こしやすい高齢者人口の増加は、市場の成長を刺激しています。これに伴い、臓器移植の普及も市場の成長に貢献しています。

さらに、3Dバイオプリンティング技術の開発や再生医療の生産における人工知能(AI)の採用など、細胞ベースの治療法におけるさまざまな技術的進歩も、成長を誘発する要因として機能しています。これらの進歩はまた、慢性的な火傷、骨欠損、および皮膚の創傷を治療するための効率的な皮膚移植移植の実施にも役立ちます。メディカルサイエンス分野における広範な研究開発(R&D)活動を含む他の要因も、ヘルスケアインフラの改善とともに、市場をさらに推進すると予想されます。

今後の展望として、世界の再生医療市場は今後5年間は力強い成長を続けると予測されています。

当レポートでは、世界の再生医療市場について調査し、市場の概要、各セグメントおよび地域別による市場規模の予測、主要企業のプロファイル、競合情勢の分析など、体系的な情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の再生医療市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響

第6章 市場内訳:タイプ別

  • 幹細胞治療
  • 生体材料
  • ヒト組織工学
  • その他

第7章 市場内訳:アプリケーション別

  • 代用骨移植片
  • 骨関節疾患
  • 皮膚科
  • 心臓血管
  • 中枢神経系
  • その他

第8章 市場内訳:エンドユーザー別

  • 病院
  • 専門クリニック
  • その他

第9章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳:国別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allergan PLC (AbbVie Inc.)
    • Amgen Inc.
    • Baxter International Inc.
    • BD (Becton, Dickinson and Company)
    • Integra Lifesciences Holdings Corporation
    • Medtronic Plc
    • Mimedx Group Inc.
    • Novartis AG
    • Osiris Therapeutics Inc. (Smith & Nephew plc)
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Regenerative Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Regenerative Medicine Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Regenerative Medicine Market: Breakup by Type (in %), 2019
  • Figure 4: Global: Regenerative Medicine Market: Breakup by Application (in %), 2019
  • Figure 5: Global: Regenerative Medicine Market: Breakup by End User (in %), 2019
  • Figure 6: Global: Regenerative Medicine Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Regenerative Medicine Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Regenerative Medicine (Stem Cell Therapy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Regenerative Medicine (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Regenerative Medicine (Biomaterial) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Regenerative Medicine (Biomaterial) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Regenerative Medicine (Tissue Engineering) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Regenerative Medicine (Tissue Engineering) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Regenerative Medicine (Other Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Regenerative Medicine (Other Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Regenerative Medicine (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Regenerative Medicine (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Regenerative Medicine (Osteoarticular Diseases) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Regenerative Medicine (Osteoarticular Diseases) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Regenerative Medicine (Dermatology) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Regenerative Medicine (Dermatology) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Regenerative Medicine (Cardiovascular) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Regenerative Medicine (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Regenerative Medicine (Central Nervous System) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Regenerative Medicine (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Regenerative Medicine (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Regenerative Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Regenerative Medicine (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Regenerative Medicine (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: Global: Regenerative Medicine (Specialty Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: Global: Regenerative Medicine (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Global: Regenerative Medicine (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Global: Regenerative Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: North America: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: North America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: United States: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: United States: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Canada: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Canada: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: Asia Pacific: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: Asia Pacific: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: China: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: China: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Japan: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Japan: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: India: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: India: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: South Korea: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: South Korea: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Australia: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Australia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Indonesia: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Indonesia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: Europe: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: Europe: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: Germany: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: Germany: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: France: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: France: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: United Kingdom: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: United Kingdom: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Italy: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Italy: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Spain: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Spain: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Russia: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Russia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Latin America: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Latin America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Brazil: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Brazil: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Mexico: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: Mexico: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 79: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 80: Middle East and Africa: Regenerative Medicine Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 81: Middle East and Africa: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 82: Global: Regenerative Medicine Industry: SWOT Analysis
  • Figure 83: Global: Regenerative Medicine Industry: Value Chain Analysis
  • Figure 84: Global: Regenerative Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Regenerative Medicine Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Regenerative Medicine Market Forecast: Breakup by Type (in Million US$), 2020-2025
  • Table 3: Global: Regenerative Medicine Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 4: Global: Regenerative Medicine Market Forecast: Breakup by End User (in Million US$), 2020-2025
  • Table 5: Global: Regenerative Medicine Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 6: Global: Regenerative Medicine Market Structure
  • Table 7: Global: Regenerative Medicine Market: Key Players
目次
Product Code: SR1019N10_Report

The global regenerative medicine market grew at a CAGR of around 16% during 2014-2019. Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer's, Parkinson's and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.

The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, oncological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient. Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further. Looking forward, IMARC Group expects the global regenerative medicine market to continue its strong growth during the next five years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global regenerative medicine market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, type, application and end user.

Breakup by Type:

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others

Breakup by Application:

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others

Breakup by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global regenerative medicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global regenerative medicine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global regenerative medicine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Regenerative Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Stem Cell Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Tissue Engineering
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Bone Graft Substitutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Osteoarticular Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dermatology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Central Nervous System
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allergan PLC (AbbVie Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BD (Becton, Dickinson and Company)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Integra Lifesciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mimedx Group Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.